The International AIDS Vaccine Initiative (IAVI) announced the appointment of Margaret McGlynn, former President of Global Vaccines and Anti-infectives at Merck, to its board of directors. IAVI said Ms. McGlynn “joins a highly independent group of 16 advisors from 10 countries who meet three times a year to assess IAVI’s progress and shape its long-term strategy.” IAVI President and CEO Seth Berkley said, “We are delighted to have Margie on the board. We expect that her business acumen, her hands-on experience in the vaccine industry and HIV marketplace, and the depth of her knowledge about health, public policy and development issues will prove invaluable to the board. She also brings considerable insight on building strong relationships between the nonprofit and private sectors in global health initiatives.” http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100706005057&newsLang=en